Concepedia

Xiaodong Luo

XL

Statistics

Publications

30

Citations

1K

H-Index

19

Active since

1997

Affiliations

Sanofi (United States)(Current)

Chinese Academy of Sciences

Janssen (United States)

Pfizer (United States)

Icahn School of Medicine at Mount Sinai

Xiaodong Luo is an author at Sanofi (United States) specializing in biostatistics, public health, and survival analysis.

Publications per year

1997–2024

30

Publications

30

Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial

Klaus F. Rabe, Bartolomé R. Celli, Michael E. Wechsler et al. · The Lancet Respiratory Medicine · 2021 · 206 citations

Medicine, Genetics, Pharmacotherapy +9

An Alternative Approach to Confidence Interval Estimation for the Win Ratio Statistic

Xiaodong Luo, Hong Tian, Surya Mohanty et al. · Biometrics · 2014 · 89 citations · Full text

Public Health, Biostatistics, Cardiology +15

Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin

Qinchang Zhu, Yi Wang, Yaping Liu et al. · European Journal of Pharmaceutical Sciences · 2011 · 70 citations

Life Sciences, Microbiology, Molecular Biology +10

A proportional likelihood ratio model

Xiaodong Luo, Wei‐Yann Tsai · Biometrika · 2011 · 49 citations

Public Health, Biostatistics, Psychiatry +10

Nonparametric estimation for right-censored length-biased data: a pseudo-partial likelihood approach

Xiaodong Luo, Wei‐Yann Tsai · Biometrika · 2009 · 47 citations

Natural Sciences, Biostatistics, Mathematics +15

1–5 of 30